Holen Sie sich die Stockscreener-App
2.10
1.87%
-0.04
Handel nachbörslich:
2.18
0.08
+3.81%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SAVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$2.14
Offen:
$2.14
24-Stunden-Volumen:
547.98K
Relative Volume:
0.38
Marktkapitalisierung:
$101.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-97.22M
KGV:
-1.5217
EPS:
-1.38
Netto-Cashflow:
$-82.44M
1W Leistung:
+0.48%
1M Leistung:
-35.19%
6M Leistung:
-4.11%
1J Leistung:
-25.66%
1-Tages-Spanne:
$2.095
$2.21
1-Wochen-Bereich:
$2.06
$2.28
52-Wochen-Spanne:
$1.15
$4.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Firmenname
Cassava Sciences Inc
Sektor
Branche
Telefon
512-501-2444
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Vergleichen Sie SAVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.10 | 103.38M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-27 | Eingeleitet | B. Riley Securities | Buy |
| 2021-02-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-01-10 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten
Signal Recap: Why Cassava Sciences Inc. Equity Warrant stock appeals to analystsJuly 2025 Trends & Growth Focused Stock Pick Reports - ulpravda.ru
Trend Review: What valuation ratios show for Cassava Sciences Inc. (PX91) stockWeekly Profit Report & Safe Entry Momentum Stock Tips - ulpravda.ru
How Cassava Sciences Inc. (PX91) stock reacts to weak economyTrade Performance Summary & AI Driven Price Forecasts - ulpravda.ru
Is Cassava Sciences Inc. stock a dividend growth opportunity - ulpravda.ru
Why Cassava Sciences Inc. (PX91) stock is a must watch tickerWeekly Trend Summary & Trade Opportunity Analysis Reports - ulpravda.ru
How Cassava Sciences Inc. stock responds to policy changesJuly 2025 Trends & Reliable Price Breakout Alerts - ulpravda.ru
Published on: 2026-01-09 03:02:15 - ulpravda.ru
Does Cassava Sciences Inc. Equity Warrant stock trade at a discount to peers2025 Market Sentiment & Free Verified High Yield Trade Plans - ulpravda.ru
Why Cassava Sciences Inc. Equity Warrant stock appeals to analystsMarket Trend Report & Technical Pattern Based Signals - ulpravda.ru
Why Cassava Sciences Inc. Equity Warrant stock is in analyst buy zoneJuly 2025 Reactions & Entry Point Confirmation Signals - ulpravda.ru
Why Cassava Sciences Inc. Equity Warrant stock remains a top recommendationREITs Market Trends & Big Gains Small Capital - ulpravda.ru
Investors Buy Large Volume of Call Options on Cassava Sciences (NASDAQ:SAVA) - MarketBeat
2026 world cup star players odds: Why Cassava Sciences Inc. Equity Warrant stock remains undervalued2026 world cup usa national team round of 16 playmakers counter attacking expert forecast expert opinion - ulpravda.ru
Sector Leaders Rotate Capital Into VCU Data Management LimitedTop Performing Stocks & Free Significant Capital Appreciation - earlytimes.in
Aug Reactions: Will Cassava Sciences Inc stock reach all time highs in 2025Market Sentiment Review & Low Volatility Stock Suggestions - moha.gov.vn
Multi Factor Analysis Ranks Ekansh Concepts Limited as Strong BuyStock Price Targets & Register for the Next Free Workshop - earlytimes.in
Quarterly Earnings: Will Cassava Sciences Inc stock see insider buyingInsider Selling & Weekly Watchlist for Hot Stocks - moha.gov.vn
HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
Cassava Sciences settles securities class action for $31.25 million By Investing.com - Investing.com Australia
Cassava Sciences agrees to settle long-running investor lawsuit - The Business Journals
Cassava Sciences agrees to $31.25 million settlement in securities class action By Investing.com - Investing.com Nigeria
Cassava Sciences agrees to $31.25 million settlement in securities class action - Investing.com
Cassava Sciences Agrees to Pay $31.25 Million to Settle Securities Class Action - marketscreener.com
[8-K] CASSAVA SCIENCES INC Reports Material Event | SAVA SEC FilingForm 8-K - Stock Titan
Cassava settles securities class action suit (SAVA:NASDAQ) - Seeking Alpha
Cassava Sciences settles securities class action for $31.25 million - Investing.com
Cassava Sciences, Inc. Reaches $31.25 Million Settlement in Consolidated Securities Class Action Litigation - Quiver Quantitative
Cassava announces agreement to settle securities class action litigation - marketscreener.com
Cassava Announces Agreement to Settle Securities Class Action Litigation - GlobeNewswire
Cassava Sciences Shares Plunge After FDA Intervention - AD HOC NEWS
Published on: 2025-12-22 08:32:25 - Улправда
Can Cassava Sciences Inc. stock outperform in 2025 bull marketQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - Улправда
Why Cassava Sciences Inc. Equity Warrant stock appeals to dividend seekersWeekly Earnings Recap & Reliable Price Breakout Alerts - Улправда
Cassava Sciences (NASDAQ:SAVA) Stock Price Down 23.9%What's Next? - MarketBeat
Will Cassava Sciences Inc. stock benefit from sector rotationQuarterly Investment Review & Real-Time Stock Price Movement Reports - Улправда
Cassava Sciences stock on track for worst day in about 9 months — what’s driving today’s selloff? - MSN
Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff? - Asianet Newsable
FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold - Benzinga
Cassava Sciences stock falls after FDA places clinical trial on hold By Investing.com - Investing.com South Africa
Cassava Sciences stock falls after FDA places clinical trial on hold - Investing.com Australia
Cassava Sciences Shares Fall Pre-Bell After FDA Clinical Hold on Simufilam Trial - marketscreener.com
Cassava Sciences down on delay for epilepsy study (SAVA:NASDAQ) - Seeking Alpha
Why Cassava Sciences Inc. Equity Warrant stock remains undervaluedPortfolio Performance Report & Weekly Return Optimization Plans - Улправда
Cassava Sciences IncOn Dec 15, FDA places full clinical hold on Cassava's trialSEC filing - marketscreener.com
Cassava Sciences receives FDA clinical hold on simufilam trial for TSC epilepsy By Investing.com - Investing.com South Africa
Cassava Sciences receives FDA clinical hold on simufilam trial for TSC epilepsy - Investing.com Nigeria
FDA Places Clinical Hold on Cassava’s Epilepsy Trial - TipRanks
Cassava Sciences Receives FDA Clinical Hold on Simufilam Trial - TradingView — Track All Markets
Published on: 2025-12-18 21:27:30 - Улправда
Finanzdaten der Cassava Sciences Inc-Aktie (SAVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):